# FDA recall D-0789-2017

> **Baxter Healthcare Corporation** · Class II · drug recall initiated 2017-05-15.

## Product

Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48

## Reason for recall

Lack of assurance of sterility: customer complaints received for the presence of leaks.

## Distribution

US and foreign countries: United Arab Emirates, Colombia, and Canada

## Key facts

- **Recall number:** D-0789-2017
- **Recalling firm:** Baxter Healthcare Corporation
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-05-15
- **Report date:** 2017-05-24
- **Termination date:** 2018-08-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Deerfield, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0789-2017

## Citation

> AI Analytics. FDA recall D-0789-2017. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-0789-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*